机器人对比开腹胰十二指肠切除术:倾向性评分匹配与CUSUM分析围术期结局
单中心回顾性队列研究将近期50例机器人胰十二指肠切除术(LR-PD)与2:1匹配的100例开腹手术(MO-PD)比较,LR-PD失血量更少、住院更短、术后淋巴漏更少,但手术时间更长,主要并发症与胰腺特异性并发症无差异。CUSUM分析显示手术时间、主要并发症和临床相关PPH的拐点分别在第51、55、53例。
要点
- 完成学习曲线后,机器人胰十二指肠切除术失血量更少、住院时间更短。
- 机器人组术后淋巴漏发生率更低,主要并发症与胰腺特异性并发症与开腹相当。
- 机器人组手术时间更长,但学习曲线后期较前期显著缩短。
核心结论
- 在高流量中心完成学习曲线后,机器人胰十二指肠切除术是开腹手术潜在安全可行的替代方案。
- 机器人组失血量更少、住院时间更短、术后淋巴漏发生率更低,但手术时间更长。
研究设计与样本
- 单中心倾向性评分匹配回顾性队列研究,使用2020年1月至2025年12月前瞻性维护的胰十二指肠切除术患者数据库。
- 近期50例连续机器人胰十二指肠切除术(LR-PD)与开腹手术按2:1匹配为100例匹配开腹组(MO-PD)。
- 亚组分析比较前50例机器人手术(ER-PD)与后续50例(LR-PD),并进行CUSUM分析。
主要发现
- 匹配后LR-PD组失血量200 mL低于MO-PD组300 mL(p=0.0012),住院时间12天短于14天(p=0.038)。
- LR-PD组手术时间582分钟长于MO-PD组362分钟(p<0.001)。
- LR-PD组术后淋巴漏发生率4%低于MO-PD组15%(p=0.045)。
- 多因素分析显示LR-PD与更低失血量(β -116.80;p=0.023)、更短住院(β -1.48;p=0.041)及更低淋巴漏风险(OR 0.30;p=0.047)独立相关,同时是更长手术时间的独立预测因素(β 99.75;p<0.001)。
- 机器人组内LR-PD手术时间582分钟短于ER-PD的705分钟(p<0.001)。
关键数值与推荐
- 主要并发症(Clavien-Dindo ≥ III)和胰腺特异性并发症两组相当。
- CUSUM分析确定手术时间、主要并发症和临床相关PPH的拐点分别在第51、55、53例。
临床怎么用
- 在高流量中心完成学习曲线后,机器人胰十二指肠切除术可作为开腹手术的可行替代,尤其关注减少失血、缩短住院和降低淋巴漏。
- 应权衡机器人手术更长的手术时间,并关注学习曲线后期手术时间逐步缩短。
局限性
- 单中心回顾性研究,结论需进一步前瞻性研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic pancreatoduodenectomy (R-PD) has emerged as a minimally invasive alternative to open pancreatoduodenectomy (O-PD), although its role remains debated due to technical complexity and heterogeneous outcomes. This study compared perioperative outcomes between R-PD and O-PD in a high-volume center while minimizing the impact of the learning curve, and additionally evaluated the progressive improvement in surgical outcomes between the early and late phases of the robotic experience through comparative analyses and CUSUM assessment. METHODS: A single-center propensity score-matched retrospective cohort study was conducted using a prospectively maintained database of patients undergoing PD between January 2020 and December 2025. The most recent 50 consecutive R-PDs (late group, LR-PD) were compared with O-PD after 2:1 matching (matched open group, MO-PD) to balance baseline characteristics. Perioperative, postoperative, and pathological outcomes were compared, and multivariable analyses were performed to identify independent predictors of key outcomes. A subgroup analysis comparing the first 50 R-PDs (early group, ER-PD) with the subsequent 50 cases (LR-PD) was also performed, along with CUSUM analyses of outcomes showing differences between the two phases of the robotic experience. RESULTS: After matching, 100 MO-PD patients were compared with 50 LR-PD patients. LR-PD was associated with significantly lower estimated blood loss (EBL) (200 vs 300 mL; p = 0.0012) and shorter length of hospital stay (LOS) (12 vs 14 days; p = 0.038), but longer operative time (OT) (582 vs 362 minutes; p < 0.001). Rates of major complications (Clavien-Dindo ≥ III) and pancreas-specific complications were comparable between groups. A significantly lower incidence of postoperative lymphatic fistula was observed in the LR-PD (4 vs 15%; p = 0.045). At multivariable analysis, the LR-PD was independently associated with lower EBL (β - 116.80; p = 0.023), shorter LOS (β - 1.48; p = 0.041), and a reduced risk of postoperative lymphatic fistula (OR 0.30; p = 0.047), while remaining an independent predictor of longer OT (β 99.75; p < 0.001). Within the R-PD, OT was significantly shorter in the LR-PD compared with the ER-PD (582 vs 705 minutes; p < 0.001). CUSUM analyses identified inflection points at cases 51, 55, and 53 for OT, major complications, and clinically relevant PPH, respectively. CONCLUSIONS: In a high-volume setting after the learning curve, R-PD is a potentially safe and feasible alternative to O-PD, offering reduced EBL, shorter LOS, and lower incidence of lymphatic fistula, despite longer OT. Further prospective studies are warranted to confirm these findings.
引用
- Aulicino M, Quero G, Fiorillo C, et al. Robotic versus open pancreatoduodenectomy after completion of the learning curve: a propensity score-matched and CUSUM analyses of perioperative outcomes. Surg Endosc. 2026. PMID: 42489883. doi:10.1007/s00464-026-13143-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。